vs
德康医疗（DXCM）与SONOCO PRODUCTS CO（SON）财务数据对比。点击上方公司名可切换其他公司
SONOCO PRODUCTS CO的季度营收约是德康医疗的1.3倍（$1.7B vs $1.3B），德康医疗净利率更高（21.2% vs 4.1%，领先17.2%），德康医疗同比增速更快（21.6% vs -1.9%），过去两年德康医疗的营收复合增速更高（12.0% vs 1.2%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
索诺科产品公司是美国多元化包装服务商，主营消费包装、工业产品、防护包装及包装供应链服务，是全球最大的复合罐、纸管和纸芯生产商。公司成立于1889年，年净销售额约73亿美元，在33个国家设有超335个运营点，员工1.99万名，业务覆盖超85个国家，总部位于南卡罗来纳州哈茨维尔。
DXCM vs SON — 直观对比
营收规模更大
SON
是对方的1.3倍
$1.3B
营收增速更快
DXCM
高出23.5%
-1.9%
净利率更高
DXCM
高出17.2%
4.1%
两年增速更快
DXCM
近两年复合增速
1.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.7B |
| 净利润 | $267.3M | $68.0M |
| 毛利率 | 62.9% | 20.6% |
| 营业利润率 | 25.6% | 7.6% |
| 净利率 | 21.2% | 4.1% |
| 营收同比 | 21.6% | -1.9% |
| 净利润同比 | 153.6% | 25.9% |
| 每股收益（稀释后） | $0.67 | $0.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMSON
| Q1 26 | $1.3B | $1.7B | ||
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.0B | $1.7B | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | $1.7B | ||
| Q2 24 | $1.0B | $1.6B |
净利润DXCMSON
| Q1 26 | $267.3M | $68.0M | ||
| Q4 25 | $267.3M | $332.2M | ||
| Q3 25 | $283.8M | $122.9M | ||
| Q2 25 | $179.8M | $493.4M | ||
| Q1 25 | $105.4M | $54.4M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $50.9M | ||
| Q2 24 | $143.5M | $90.8M |
毛利率DXCMSON
| Q1 26 | 62.9% | 20.6% | ||
| Q4 25 | 62.9% | 19.6% | ||
| Q3 25 | 60.5% | 21.9% | ||
| Q2 25 | 59.5% | 21.3% | ||
| Q1 25 | 56.9% | 20.7% | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | 21.4% | ||
| Q2 24 | 62.4% | 22.0% |
营业利润率DXCMSON
| Q1 26 | 25.6% | 7.6% | ||
| Q4 25 | 25.6% | 29.4% | ||
| Q3 25 | 20.1% | 9.1% | ||
| Q2 25 | 18.4% | 9.2% | ||
| Q1 25 | 12.9% | 7.4% | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | 7.6% | ||
| Q2 24 | 15.7% | 8.6% |
净利率DXCMSON
| Q1 26 | 21.2% | 4.1% | ||
| Q4 25 | 21.2% | 18.8% | ||
| Q3 25 | 23.5% | 5.8% | ||
| Q2 25 | 15.5% | 25.8% | ||
| Q1 25 | 10.2% | 3.2% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | 3.0% | ||
| Q2 24 | 14.3% | 5.6% |
每股收益（稀释后）DXCMSON
| Q1 26 | $0.67 | $0.68 | ||
| Q4 25 | $0.67 | $3.33 | ||
| Q3 25 | $0.70 | $1.23 | ||
| Q2 25 | $0.45 | $4.96 | ||
| Q1 25 | $0.27 | $0.55 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | $0.51 | ||
| Q2 24 | $0.35 | $0.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $224.5M |
| 总债务越低越好 | — | $3.5B |
| 股东权益账面价值 | $2.7B | $3.6B |
| 总资产 | $6.3B | $11.1B |
| 负债/权益比越低杠杆越低 | — | 0.97× |
8季度趋势，按日历期对齐
现金及短期投资DXCMSON
| Q1 26 | $917.7M | $224.5M | ||
| Q4 25 | $917.7M | $378.4M | ||
| Q3 25 | $1.8B | $244.9M | ||
| Q2 25 | $1.2B | $329.8M | ||
| Q1 25 | $904.9M | $181.8M | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | $1.9B | ||
| Q2 24 | $939.2M | $140.2M |
总债务DXCMSON
| Q1 26 | — | $3.5B | ||
| Q4 25 | — | $3.8B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $5.0B | ||
| Q1 25 | — | $5.0B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $2.5B |
股东权益DXCMSON
| Q1 26 | $2.7B | $3.6B | ||
| Q4 25 | $2.7B | $3.6B | ||
| Q3 25 | $2.7B | $3.3B | ||
| Q2 25 | $2.6B | $3.2B | ||
| Q1 25 | $2.3B | $2.4B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | $2.5B | ||
| Q2 24 | $2.4B | $2.4B |
总资产DXCMSON
| Q1 26 | $6.3B | $11.1B | ||
| Q4 25 | $6.3B | $11.2B | ||
| Q3 25 | $7.5B | $11.7B | ||
| Q2 25 | $7.3B | $12.0B | ||
| Q1 25 | $6.8B | $12.7B | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | $9.0B | ||
| Q2 24 | $6.8B | $7.2B |
负债/权益比DXCMSON
| Q1 26 | — | 0.97× | ||
| Q4 25 | — | 1.05× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.54× | ||
| Q1 25 | — | 2.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.74× | ||
| Q2 24 | — | 1.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $-428.3B |
| 自由现金流率自由现金流/营收 | — | -25547.4% |
| 资本支出强度资本支出/营收 | — | 3600.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-427.6B |
8季度趋势，按日历期对齐
经营现金流DXCMSON
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $412.9M | ||
| Q3 25 | $659.9M | $291.5M | ||
| Q2 25 | $303.0M | $193.4M | ||
| Q1 25 | $183.8M | $-208.1M | ||
| Q4 24 | $301.4M | — | ||
| Q3 24 | $199.5M | $162.1M | ||
| Q2 24 | $279.4M | $109.3M |
自由现金流DXCMSON
| Q1 26 | — | $-428.3B | ||
| Q4 25 | $192.1M | $322.3M | ||
| Q3 25 | $579.4M | $225.6M | ||
| Q2 25 | $208.9M | $98.6M | ||
| Q1 25 | $96.8M | $-300.8M | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | $70.5M | ||
| Q2 24 | $213.3M | $16.0M |
自由现金流率DXCMSON
| Q1 26 | — | -25547.4% | ||
| Q4 25 | 15.3% | 18.2% | ||
| Q3 25 | 47.9% | 10.6% | ||
| Q2 25 | 18.1% | 5.2% | ||
| Q1 25 | 9.3% | -17.6% | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | 4.2% | ||
| Q2 24 | 21.2% | 1.0% |
资本支出强度DXCMSON
| Q1 26 | — | 3600.5% | ||
| Q4 25 | 8.1% | 5.1% | ||
| Q3 25 | 6.7% | 3.1% | ||
| Q2 25 | 8.1% | 5.0% | ||
| Q1 25 | 8.4% | 5.4% | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | 5.5% | ||
| Q2 24 | 6.6% | 5.7% |
现金转化率DXCMSON
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.24× | ||
| Q3 25 | 2.33× | 2.37× | ||
| Q2 25 | 1.69× | 0.39× | ||
| Q1 25 | 1.74× | -3.82× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 3.18× | ||
| Q2 24 | 1.95× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
SON
| Consumer Packaging | $1.1B | 65% |
| Industrial Paper Packaging | $587.5M | 35% |
| All Other | $55.1M | 3% |
